These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35035363)

  • 41. Behavioural Phenomena of Family Firm Control Diversity and R&D Investment with Moderating Role CEO Compensation.
    Ghafoor S; Zulfiqar M; Wang M; Wang C; Islam MR
    Psychol Res Behav Manag; 2023; 16():397-417. PubMed ID: 36819007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CEO Overconfidence, Corporate Governance, and R&D Smoothing in Technology-Based Entrepreneurial Firms.
    Huang Y; Wang X; Li Y; Yu X
    Front Psychol; 2022; 13():944117. PubMed ID: 35910989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How does social responsibility investment strategy contribute to hospitality firms' recovery from public health emergencies? The case of COVID-19 pandemic.
    Wu D; Li H; Yang J
    Int J Hosp Manag; 2023 Aug; 113():103530. PubMed ID: 37292494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of CEO Identity on Non-family Managers' Pay Dispersion in Family Firms: A Social Comparison Perspective.
    Zhang W; Chen L; Zhu JA
    Front Psychol; 2021; 12():683011. PubMed ID: 34659004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Do political incentives promote or inhibit corporate social responsibility? The role of local officials' tenure.
    Wu Y
    PLoS One; 2023; 18(3):e0283183. PubMed ID: 36930614
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comprehensive dataset of board of directors attributes of Pakistan stock exchange listed non-financial firms.
    Khan S; Kamal Y
    Data Brief; 2022 Apr; 41():107879. PubMed ID: 35146095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel investigation of the influence of corporate governance on firms' credit ratings.
    Alkhawaldeh AAK; Jaber JJ; Boughaci D; Ismail N
    PLoS One; 2021; 16(5):e0250242. PubMed ID: 33945537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Impact of Financial Redundancy on Corporate Social Responsibility Performance: Evidence From Chinese Listed Firms.
    He L; Gan S; Zhong T
    Front Psychol; 2022; 13():882731. PubMed ID: 35664182
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Will Green CSR Enhance Innovation? A Perspective of Public Visibility and Firm Transparency.
    Wu W; Liu Y; Chin T; Zhu W
    Int J Environ Res Public Health; 2018 Feb; 15(2):. PubMed ID: 29401714
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CEO Tenure, CEO Compensation, Corporate Social and Environmental Performance in China: The Moderating Role of Coastal and Non-coastal Areas.
    Khan TM; Bai G; Fareed Z; Quresh S; Khalid Z; Khan WA
    Front Psychol; 2020; 11():574062. PubMed ID: 33551900
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do corporate anti-bribery and corruption commitments enhance environmental management performance? The moderating role of corporate social responsibility accountability and executive compensation governance.
    Sarhan AA; Gerged AM
    J Environ Manage; 2023 Sep; 341():118063. PubMed ID: 37146491
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COVID-19 Outbreak and Financial Performance of Chinese Listed Firms: Evidence From Corporate Culture and Corporate Social Responsibility.
    Sun Y; Li Y
    Front Public Health; 2021; 9():710743. PubMed ID: 34604155
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diversity of returnee executives' foreign experience and corporate social responsibility performance.
    Wu Y; Zhang W; Li H
    PLoS One; 2024; 19(4):e0300262. PubMed ID: 38557680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Corporate social responsibility in global health: an exploratory study of multinational pharmaceutical firms.
    Droppert H; Bennett S
    Global Health; 2015 Apr; 11():15. PubMed ID: 25886175
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evidence in Asian Food Industry: Intellectual Capital, Corporate Financial Performance, and Corporate Social Responsibility.
    Tsai CH; Mutuc EB
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31968553
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chief Executive Officer Tenacity and Employee Intrapreneurial Behavior: The Mediating Role of Corporate Social Responsibility.
    Huang Z
    Front Psychol; 2022; 13():829567. PubMed ID: 35350727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How Corporate Social Responsibility Boosts Corporate Financial and Non-financial Performance: The Moderating Role of Ethical Leadership.
    Bouichou SI; Wang L; Zulfiqar S
    Front Psychol; 2022; 13():871334. PubMed ID: 35693531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Power of Unrequited Love: The Parasocial Relationship, Trust, and Organizational Identification Between Middle-Level Managers and CEOs.
    Liao Y; Lin B; Zhou H; Yang X
    Front Psychol; 2021; 12():689511. PubMed ID: 34566768
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Role of Transformational Leadership on Firm Performance: Mediating Effect of Corporate Sustainability and Moderating Effect of Knowledge-Sharing.
    Shahzad MA; Iqbal T; Jan N; Zahid M
    Front Psychol; 2022; 13():883224. PubMed ID: 35874334
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Corporate Social Responsibility and Directors' and Officers' Liability Risk: The Moderating Effect of Risk Environment and Growth Potential.
    Lu H; Boyer MM; Kleffner A
    Bus Soc; 2024 Mar; 63(3):668-711. PubMed ID: 38374889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.